In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

Background: Second-generation long-acting insulin glargine 300 U/mL (Gla-300) and degludec 100 U/mL (Deg-100) provide novel basal insulin therapies for the treatment of type 1 diabetes (T1D). Both offer a flatter pharmacokinetic (PK) profile than the previous generation of long-acting insulins, thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiavon, Michele, Visentin, Roberto, Giegerich, Clemens, Sieber, Jochen, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407002/
https://www.ncbi.nlm.nih.gov/pubmed/32125178
http://dx.doi.org/10.1089/dia.2020.0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407002/
https://www.ncbi.nlm.nih.gov/pubmed/32125178
http://dx.doi.org/10.1089/dia.2020.0027

Ejemplares similares